Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,295 | -64,403 | -31,021 | -65,002 | -30,515 |
| Depreciation Amortization | 568 | 290 | 16 | -3,238 | -2,736 |
| Accounts receivable | -1,857 | -345 | 70 | 81,311 | 63,823 |
| Accounts payable and accrued liabilities | -1,880 | -2,192 | -1,362 | 2,392 | 1,556 |
| Other Working Capital | -21,822 | -17,304 | -11,814 | 34,859 | 18,168 |
| Other Operating Activity | 15,082 | 12,798 | 6,216 | -65,632 | -51,077 |
| Operating Cash Flow | $-102,204 | $-71,156 | $-37,895 | $-15,310 | $-781 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,970 | -1,763 | -658 | -3,521 | -3,366 |
| Purchase Of Investment | -121,426 | -114,790 | -76,924 | -465,685 | -334,667 |
| Sale Of Investment | 201,418 | 159,687 | 118,783 | 374,347 | 270,377 |
| Investing Cash Flow | $78,022 | $43,134 | $41,201 | $-94,859 | $-67,656 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 680 | 595 | 82 | 114,015 | 113,441 |
| Financing Cash Flow | $680 | $595 | $82 | $114,015 | $113,441 |
| Beginning Cash Position | 74,241 | 74,241 | 74,241 | 70,395 | 70,395 |
| End Cash Position | 50,739 | 46,814 | 77,629 | 74,241 | 115,399 |
| Net Cash Flow | $-23,502 | $-27,427 | $3,388 | $3,846 | $45,004 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,204 | -71,156 | -37,895 | -15,310 | -781 |
| Capital Expenditure | -1,970 | -1,763 | -658 | -3,521 | -3,366 |
| Free Cash Flow | -104,174 | -72,919 | -38,553 | -18,831 | -4,147 |